What is Crossroads Genetics?
Crossroads Genetics operates as a specialized provider of high-quality genetic sires, catering to the sophisticated needs of the swine production market. The company maintains a robust portfolio that includes current, retired, and Hall of Fame sires, serving as a critical resource for breeders aiming to optimize herd performance. Through the provision of AI certificates and a comprehensive boar catalog, the firm facilitates seamless access to elite genetic material. Their market position is reinforced by a track record of success in state and national competitions, which serves as a benchmark for their commitment to breeding excellence and genetic advancement.
How much funding has Crossroads Genetics raised?
Crossroads Genetics has raised a total of $33K across 1 funding round:
Debt
$33K
Debt (2021): $33K with participation from PPP
Key Investors in Crossroads Genetics
PPP
Public-Private Partnership
What's next for Crossroads Genetics?
With the infusion of this recent capital, Crossroads Genetics is poised to accelerate its strategic growth initiatives. The company is expected to focus on expanding its genetic library and enhancing its distribution infrastructure to meet the rising demand for superior swine genetics. By prioritizing research and development, the firm aims to maintain its competitive edge, ensuring that producers have access to the most advanced breeding solutions available. This phase of development will likely involve scaling operational capacity to support a broader client base while continuing to uphold the high standards of quality that have defined their brand in the agricultural sector.
See full Crossroads Genetics company page
